Walleye Trading LLC Vaxart, Inc. Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $7,020 - $20,966	-9,360 Reduced 37.81%	15,396 $14,000
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $51,740 - $111,402	24,756 New	24,756 $54,000
Q2 2022 Aug 08, 2022	SELL	$2.7 - $5.28 $32,186 - $62,942	-11,921 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $28,850 - $44,654	-6,725 Reduced 36.07%	11,921 $60,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $107,587 - $148,422	18,646 New	18,646 $117,000
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $28,220 - $41,463	-4,231 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $21,408 - $45,610	4,231 New	4,231 $32,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.